← Open Payments lookup

ADOMAH OPONG: Open Payments

NPI 1518215151 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$857 in 26 payments from 11 companies in 2025. Trend: 2023 $745 · 2024 $715 · 2025 $857

Food & beverage: $857
CompanyPaymentsAmount
Genentech, Inc.2$268
Novartis Pharmaceuticals Corporation9$217
Alexion Pharmaceuticals, Inc.3$76
Azurity Pharmaceuticals, Inc.2$61
Astellas Pharma US Inc2$56
Daiichi Sankyo Inc.2$55
Celgene Corporation2$37
Stemline Therapeutics Inc.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$21
Janssen Biotech, Inc.1$21

Products named: Venclexta, Fabhalta, ULTOMIRIS, SCEMBLIX, DANZITEN, Cresemba, Vanflyta, REBLOZYL.

Industry payments across NY — which companies pay providers there.